Product Information
TI17 is a selective TRIP13 inhibitor with anticancer activity that inhibits the proliferation of multiple myeloma (MM) cells and induces cycle arrest and apoptosis in MM cells.
Chemical properties
Technical inquiry about: TM-T87526 TI17
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.